Streptozotocin-induced diabetes is associated with changes in NGF levels in pancreas and brain

Archives Italiennes de Biologie

Volumn 145, Issue 2, 2007, Pages 87-97

  Sposato, V ^a   Manni, L ^a   Chaldakov, G N ^b   Aloe, L ^a  

^a CNR   (Italy)

^b MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE GROWTH FACTOR; NERVE GROWTH FACTOR RECEPTOR; PROTEIN P75; PROTEIN TYROSINE KINASE A; STREPTOZOCIN; VASCULOTROPIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BODY WEIGHT; BRAIN; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; HYPOTHALAMUS; IMMUNOHISTOCHEMISTRY; LANGERHANS CELL; NONHUMAN; PANCREAS; PANCREAS ISLET CELL; PROTEIN EXPRESSION; RAT;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BLOOD GLUCOSE; BODY WEIGHT; BRAIN; CEREBRAL ARTERIES; CYTOPROTECTION; DIABETES MELLITUS, EXPERIMENTAL; DISEASE MODELS, ANIMAL; DOWN-REGULATION; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOHISTOCHEMISTRY; ISLETS OF LANGERHANS; NERVE GROWTH FACTOR; PANCREAS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, TRKA; RECEPTORS, NERVE GROWTH FACTOR; STREPTOZOCIN; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; RATTUS; RODENTIA;

EID: 34248583151     PISSN: 00039829     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. ADEGHATE, E. Distribution of calcitonin-gene-related peptide, neuropeptide-Y, vasoactive intestinal polypeptide, cholecystokinin-8, substance P and islet peptides in the pancreas of normal and diabetic rats. Neuropeptides, 33: 227-235, 1999.
2. ALOE, L., TIRASSA, P. AND BRACCI- LAUDIERO, L. Nerve growth factor in neurological and non-neurological diseases: basic findings and emerging pharmacological prospectives. Curr. Pharm. Des., 7:113-23, 2001.
3. ALOE, L. Nerve growth factor, human skin ulcers and vascularization. Our experience. Prog. Brain Res., 146:515-22, 2004.
4. ANAND, P. Nerve growth factor and their receptors in human sensory neuropathies. Prog. Brain Res., 146: 477-492, 2004.
5. APFEL, S.C., AREZZO, J.C., BROWNLEE, M., FEDEROFF, H. AND KESSLER, J.A. Nerve growth factor administration protects against experimental diabetic sensory neuropathy. Brain Res., 34: 7-12, 1994.
6. BONOVAS, S., PEPONIS, V. AND FILIOUSSI, K. Diabetes mellitus as a risk factor for primary open-amgle glaucoma: a meta-analysis. Diabet. Med., 21: 609-614, 2004.
7. BROWNLEE, M. Advanced products of nonenzymatic glycosylation and the pathogenesis of diabetic complications. Pp. 279-291. In: RIFKIN, H. AND PORTE, D. (Eds.), Diabetes Mellitus. Theory and Practice. Elsevier, 1990.
8. CHALDAKOV, G.N., FIORE, M., STANKULOV, I.S., MANNI, L., HRISTOVA, M.G., ANTONELLI, A., GHENEV, P.I. AND ALOE, L. Neurotrophin presence in human coronary atherosclerosis and metabolic syndrome: a role for NGF and BDNF in cardiovascular disease? Prog. Brain Res., 146: 279-289, 2004.
9. CHALDAKOV, G.N., FIORE, M., TONCHEV, A.B. AND ALOE, L. Adipopharmacology, a novel drug discovery approach: a metabotrophic perspective. Lett. Drug Des. Discov., 3: 2006. In press.
10. NTR and Trk: a two-receptor system. Trends Neurosci., 18: 321-326, 1995.
11. CHIARETTI, A., PIASTRA, M., CARESTA, E., NANNI, L. AND ALOE, L. Improving ischaemic skin revascularisation by nerve growth factor in a child with crush syndrome. Arch. Dis. Child, 87: 446-448, 2002.
12. CUELLO, A.C. Brain Microdissection Techniques. IBRO Handbook Series. Chister: John Wiley & Sons, 1983.
13. DI LUCA, M., RUTS, L., GARDONI, F., CATTABENI, F., BIESSELS, G.J. AND GIPSEN, W.H. NMDA receptor subunits are modified transcriptionally and post-translationally in the brain of streptozotocin-diabetic rats. Diabetology, 42: 693-701, 1999.
14. EMANUELI, C., SALIS, M.B., PINNA, A., GRAIANI, G., MANNI, L. AND MADEDDU, P. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Circulation, 106: 2257-2262, 2002.
15. FARADIJI, V. AND SOTELO, J. Low serum levels of nerve growth facto in diabetic neuropathy. Acta Neurol. Scand., 81: 402-406, 1990.
16. GENERINI, S., TUVERI, M.A., MATUCCI CERINIC, M., MASTINU, F., MANNI, L. AND ALOE, L. Topical application of nerve growth factor in human diabetic foot ulcers. A study of three cases. Exp. Clin. Endocrinol. Diabetes, 112: 542-544, 2004.
17. GRAIANI, G., EMANUELI, C., DESORTES, E., VAN LINTHOUT, S., PINNA, A., FIGUEROA, C.D., MANNI, L. AND MADEDDU, P. Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice. Diabetologia, 47: 1047-1054, 2004.
18. GRUNBLATT, E., HOYER, S. AND RIEDERER, P. Gene expression profile in streptozotocin rat model for sporadic Alzheimer's disease. J. Neural. Transm., 111: 367-386, 2004.
19. GRUNBLATT, E., KOUTSILIERI, E., HOYER, S. AND RIEDERER, P. Gene expression alterations in brain areas of intracerebroventricular streptozotocin treated rat. J. Alzheimers Dis., 3: 261-271, 2006.
20. HANSEN-ALGENSTAEDT, N., ALGENSTAEDT, P., SCHAEFER, C., HAMANN, A., WOLFRAM, L., CINGOZ, G., KILIC, N., SCHWARZLOH, B., SCHROEDER, M., JOSCHECK, C., WIESUER, L., RUTHER, W. AND ERGUN, S. Neural driven angiogenesis by overexpression of nerve growth factor. Histochem. Cell Biol., 125: 637-649, 2005.
21. HELLWEG, R., WOHRLE, M., HARTUNG, H.D., STRACKE, H., HOCK, C. AND FEDERLIN, K. Diabetes mellitus-associated decrease in nerve growth factor levels is reversed by allogeneic pancreatic islet transplantation. Neurosci. Lett., 125: 1-4, 1991.
22. HELLWEG, R. AND HARTUNG, H.D. Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: a possible role for NGF in the pathogenesis of diabetic neuropathy. J. Neurosci. Res., 26: 258-267, 1990.
23. KAWAMOTO, K. AND MATSUDA, H. Nerve growth factor and wound healing. Prog. Brain Res., 146: 369-384, 2004.
24. LAGNADO, M.L., CROWE, R., LINCOLN, J. AND BURSTOCK, G. Reduction of nerves containing vasoactive polypeptide and serotonin, but not neuropeptide Y and chatecholamine, in cerebtal blood vessels of 8-week streptozoticin-induced diabetic rat. Blood Vessels, 24: 169-180, 1987.
25. LAMBIASE, A., RAMA, P., BONINI, S., CAPRIOGUO, G. AND ALOE, L. Topical treatment with nerve growth factor for corneal neurotrophic ulcers. N. Engl. J. Med., 338: 1174-1180, 1998.
26. LARRIETA, M.E., VITAL, P., MENDOZA- RODRIGUEZ, A., CERBON, M. AND HIRIART, M. Nerve growth factor increases in pancreatic beta cells after streptozotocin-induced damage in rats. Exp. Biol. Med., 231: 396-402, 2006.
27. LAZAROVICI, P., MARCINKIEWICZ, C. AND LELKES, P.I. Cross talk between cardiovascular and nervous system: neurotrophic effects of vascular endothelial growth factor (VEGF) and angiogenic effect of nerve growth factor (NGF) - implications in drug development. Curr. Pharm. Des., 12: 2609-2622, 2006.
28. LEVI-MONTALCINI, R. The nerve growth factor: Thirty-five years later. Science, 237: 1154-1162, 1987.
29. LIBERINI, P. AND CUELLO, A.C. Effects of nerve growth factor in primate models of neurodegeneration: potential relevance in clinical neurology. Rev. Neurosci., 5: 89-104, 1994.
30. MATSUDA, H.H., KOYAMA H., SATO, H., SAWADA J., ITAKURA, A., TANAKA, A., MATSUMOTO, M., KONNO, K., USHIO, H. AND MATSUDA, K. Role of nerve growth factor in cutaneous wound healing: accelerating effect in normal and healing-impaaired diabetic mice. J. Expt. Med., 187: 297-306.
31. MANNI, L., NIKOLOVA, V., VYAGOVA, D., CHALDAKOV, G.N. AND ALOE, L. Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int. J. Cardiol., 102: 169-171, 2005.
32. MIAO, G., MACE, J., KIRBY, M., PEVERINI, R., CHINNOCK, R., SHAPIRO, J. AND HATHOUT, E. In vitro and in vivo improvement of islet survival following treatment with nerve growth factor. Transplantation, 81: 519-524, 2006.
33. NITTA, A., MURAI, R., SUSUKI, N., ITO, H., MOMOTO, H., KATOH, G., FURUKAWA, Y. AND FURUKAWA, S. Diabetic neuropathies in brain are induced by deficiency of BDNF. Neurotoxicol. Teratol., 24: 695-701, 2002.
34. NTR in rat islets and INS-1E. Regul. Pept., 135: 30-38, 2006.
35. REIMER, M.K., MOKSHAGUNDAM, S.P., WYLER, K., SUNDLER, F., AHREN, B. AND STAGNER, J.I. Local growth factors are beneficial for the autonomic reinnervation of transplanted islets in rats. Pancreas, 26: 392-397, 2003.
36. ROSEBAUM, T., VIDALTAMAYO, R., SANCHEZ- SOTO, M.C., ZENTELLA, A. AND HIRIART, M. Pancreatic beta cells synthetize and secrete nerve growth factor. Proc. Natl. Acad. Sci., 95: 7784-7788, 1998.
37. SALIS, M.B., GRAIANI, G., DESORTIS, E., CALDWELL R.B., MADEDDU, P. AND EMANUELI, C. Nerve growth factor supplementation reverses the impairment, induced by type 1 diabetes, of hindlimb post-ischemic recovery in mice. Diabetologia, 47: 1055-1063, 2004.
38. SAMII, A., UNGER, J. AND LANGE, W. Vascular endothelial growth factor expression in peripheral nerves and dorsal root ganglia in diabetic neuropathy in rats. Neurosci. Lett., 262: 159-162, 1999.
39. SEEMAYER, T.A., OLIGNY, L.L., TANNENBAUM, G.S., GOLDMAN, H. AND COLLE, E. Animal model of human disease. Diabetes mellitus. Am. J. Pathol., 101: 485-488, 1980.
40. SIGRIST, S., MECHINE-NEUVILLE, A., MANDES, K., CALENDA, V., BRAUN, S., LEGEAY, G., BELLOCQ, J.P., PINGET, M. AND KESSLER, L. Influence of VEGF on the viability of encapsulated pancreatic rat islets after transplantation in diabetic mice. Cell. Transplant., 12: 627-635, 2003.
41. SOFRONIEW, M.V., HOWE, C.L. AND MOBLEY, W.C. Nerve growth factor signaling, neuroprotection, and neural repair. Annu. Rev. Neurosci., 24: 1217-1281, 2001.
42. TURRINI, P., GAETANO, C., ANTONELLI, A., CAPOGROSSI, M.C. AND ALOE, L. Nerve growth factor induces angiogenic activity in a mouse model of hindlimb ischemia. Neurosci. Lett., 323: 109-112, 2002.
43. TUVERI, M., GENERINI, S., MATUCCI- CERINIC, M. AND ALOE, L. NGF, a useful tool in the treatment of chronic vasculitic ulcers in rheumatoid arthritis. Lancet, 356: 1739-1740, 2000.
44. VIDALTAMAYO, R., SANCHEZ-SOTO, M.C. AND HIRIART, M. Nerve growth factor increase sodium channel expression in pancreatic beta cells: implications for insulin secretion. FASEB, 16: 891-892, 2002.
45. VIDALTAMAYO, R., MERY, C.M., ANGELES- ANGELES, A., ROBLES-DIAZ, G. AND HIRIART, M. Expression of nerve growth factor in human pancreatic beta cells. Growth Factors, 21: 103-107, 2003.